Website | oxcp.com |
Blog | oxcp.com/about-us... |
@oxford_capital | |
Phone | +44 1865 860 760 |
[email protected] | |
Employees | |
Founded | 1999 |
Description | Venture Capital Firm |
Total | $166M |
Oxford Capital Infrastructure EIS, 1/2012 ^{} | £22.8M |
Oxford Gateway IHT Portfolio, 1/2009 ^{} | £1.21M |
Oxford Gateway Portfolio, 1/2010 ^{} | £12.7M |
Oxford Gateway Fund 2, 1/2004 ^{} | £11.2M |
Oxford Gateway Fund 3, 1/2006 ^{} | £11.6M |
Oxford Gateway Fund 4, 1/2007 ^{} | £12.3M |
Oxford Gateway Fund 5, 1/2008 ^{} | £7.03M |
Oxford Capital Solar EIS, 1/2011 ^{} | £8.99M |
Oxford Capital Solar EIS II, 1/2012 ^{} | £9.82M |
Oxford Capital is a specialist investment firm focused on growth capital, investing across three super-growth sectors: communications, healthcare, and sustainability.
Our competitive edge comes from deep experience, an international network, and a base at the centre of the one of the worldâ€™s leading innovation centres. We excel in assisting companies to achieve scale internationally.
Company | Date | Round | Size | Participants |
Arkivum ^{} | 4/2014 | Series C | £1.9M | 3 |
Linkdex ^{} | 3/2014 | Venture Round | 2 | |
Green Biologics ^{} | 12/2013 | Series B | £15.4M | 5 |
Linkdex ^{} | 12/2013 | Venture Round | $3M | 1 |
Green Biologics ^{} | 7/2013 | Venture Round | £2M | 3 |
Helveta ^{} | 6/2013 | Venture Round | £1.24M | 3 |
Exosect ^{} | 5/2013 | Venture Round | £2.5M | 3 |
Celoxica ^{} | 5/2013 | Venture Round | $3M | 1 |
Abiquo ^{} | 4/2013 | Venture Round | $5M | 3 |
MirriAd ^{} | 3/2013 | Venture Round | £3.65M | 1 |
PowerOasis ^{} | 2/2013 | Venture Round | £750k | 3 |
Cognia ^{} | 11/2012 | Venture Round | £450k | 2 |
Exosect ^{} | 11/2012 | Venture Round | 3 | |
iJento ^{} | 10/2012 | Venture Round | $8M | 3 |
MirriAd ^{} | 7/2012 | Venture Round | 1 | |
Green Biologics ^{} | 5/2012 | Venture Round | £3.21M | 3 |
BagThat ^{} | 5/2012 | Venture Round | $3.2M | 1 |
Celoxica ^{} | 5/2012 | Venture Round | £643k | 5 |
Gazoob ^{} | 4/2012 | Venture Round | £2M | 1 |
PowerOasis ^{} | 2/2012 | Venture Round | £2.4M | 2 |
Sirigen ^{} | 2/2012 | Venture Round | £2M | 5 |
Oxitec ^{} | 2/2012 | Venture Round | £8M | 1 |
Exosect ^{} | 1/2012 | Venture Round | £1.45M | 1 |
Helveta ^{} | 11/2011 | Venture Round | £4M | 2 |
Cognia ^{} | 10/2011 | Venture Round | £400k | 2 |
Exosect ^{} | 10/2011 | Venture Round | £800k | 4 |
Sirigen ^{} | 10/2011 | Venture Round | £750k | 5 |
MirriAd ^{} | 9/2011 | Venture Round | £500k | 1 |
iJento ^{} | 9/2011 | Venture Round | $8M | 3 |
PowerOasis ^{} | 7/2011 | Venture Round | £3.5M | 1 |
Handmade Mobile ^{} | 7/2011 | Venture Round | £1.5M | 1 |
Cognia ^{} | 6/2011 | Venture Round | £2M | 2 |
Site Intelligence ^{} | 5/2011 | Venture Round | $7M | 2 |
Celoxica ^{} | 5/2011 | Venture Round | £3.1M | 4 |
Helveta ^{} | 4/2011 | Venture Round | £2.87M | 1 |
MirriAd ^{} | 4/2011 | Venture Round | £500k | 1 |
Oxitec ^{} | 3/2011 | Venture Round | £3.47M | 1 |
MirriAd ^{} | 11/2010 | Venture Round | 2 | |
Flirtomatic ^{} | 11/2010 | Venture Round | 1 | |
Site Intelligence ^{} | 11/2010 | Venture Round | 1 | |
Sirigen ^{} | 11/2010 | Venture Round | $3.83M | 4 |
iJento ^{} | 9/2010 | Venture Round | £1.08M | 1 |
Oxford BioTherapeutics ^{} | 8/2010 | Venture Round | £708k | 2 |
Celoxica ^{} | 8/2010 | Venture Round | £1.1M | 4 |
Sirigen ^{} | 8/2010 | Venture Round | £300k | 2 |
Green Biologics ^{} | 7/2010 | Series B | $6.1M | 4 |
Ad.IQ ^{} | 7/2010 | Venture Round | £313k | 1 |
Oxford BioTherapeutics ^{} | 5/2010 | Venture Round | £708k | 2 |
Helveta ^{} | 5/2010 | Venture Round | $7.27M | 5 |
Sirigen ^{} | 4/2010 | Venture Round | £574k | 2 |
Arieso ^{} | 4/2010 | Venture Round | $2.21M | 4 |
Veryan Medical ^{} | 4/2010 | Series B | $5.4M | 4 |
Rostima ^{} | 4/2010 | Venture Round | 1 | |
Oxford BioTherapeutics ^{} | 3/2010 | Venture Round | £746k | 3 |
Oxitec ^{} | 12/2009 | Venture Round | £1.86M | 2 |
Exosect ^{} | 12/2009 | Venture Round | £2M | 3 |
Inetec ^{} | 12/2009 | Venture Round | £130k | 1 |
Rostima ^{} | 9/2009 | Venture Round | £800k | 3 |
Rostima ^{} | 8/2009 | Venture Round | £140k | 2 |
Sphere Medical Holding ^{} | 6/2009 | Venture Round | £12.5k | 1 |
Helveta ^{} | 6/2009 | Venture Round | £1.31M | 2 |
Sirigen ^{} | 5/2009 | Venture Round | £1.64M | 3 |
Rostima ^{} | 4/2009 | Venture Round | £500k | 2 |
Helveta ^{} | 4/2009 | Venture Round | £200k | 2 |
Arieso ^{} | 3/2009 | Venture Round | £1M | 2 |
Oxford BioTherapeutics ^{} | 2/2009 | Venture Round | £800k | 3 |
Ad.IQ ^{} | 2/2009 | Venture Round | £362k | 3 |
Green Biologics ^{} | 2/2009 | Venture Round | £1.02M | 3 |
Rostima ^{} | 12/2008 | Venture Round | £571k | 2 |
Exosect ^{} | 11/2008 | Venture Round | £1.84M | 3 |
Rostima ^{} | 10/2008 | Venture Round | £250k | 2 |
Sphere Medical Holding ^{} | 8/2008 | Venture Round | £6M | 3 |
Oxford BioTherapeutics ^{} | 8/2008 | Venture Round | £700k | 3 |
Streamline Computing ^{} | 5/2008 | Venture Round | £900k | 3 |
Celoxica ^{} | 5/2008 | Venture Round | £2M | 3 |
Inetec ^{} | 5/2008 | Venture Round | £900k | 2 |
Sirigen ^{} | 4/2008 | Venture Round | £2M | 2 |
Ad.IQ ^{} | 3/2008 | Venture Round | £683k | 1 |
Rostima ^{} | 3/2008 | Venture Round | £700k | 2 |
Helveta ^{} | 3/2008 | Venture Round | $2.9M | 2 |
Exosect ^{} | 2/2008 | Venture Round | £3.3M | 3 |
Arieso ^{} | 2/2008 | Venture Round | £3M | 4 |
Microbial Solutions ^{} | 1/2008 | Venture Round | £1.2M | 3 |
Oxonica ^{} | 12/2007 | Venture Round | £4.2M | 3 |
Teepix ^{} | 11/2007 | Venture Round | £800k | 1 |
Oxitec ^{} | 10/2007 | Venture Round | £1.5M | 2 |
Green Biologics ^{} | 10/2007 | Venture Round | $3.2M | 2 |
Ad.IQ ^{} | 8/2007 | Venture Round | £771k | 3 |
Glide Pharma ^{} | 8/2007 | Venture Round | £2.3M | 2 |
g-Nostics ^{} | 7/2007 | Venture Round | £258k | 2 |
Veryan Medical ^{} | 7/2007 | Venture Round | £3.1M | 3 |
Inetec ^{} | 3/2007 | Venture Round | £1M | 2 |
Rostima ^{} | 3/2007 | Venture Round | $3.89M | 2 |
Celoxica ^{} | 1/2007 | Venture Round | £3.01M | 7 |
Oxford BioTherapeutics ^{} | 1/2007 | Venture Round | £2M | 3 |
Orthomimetics ^{} | 12/2006 | Venture Round | $5M | 4 |
Ad.IQ ^{} | 12/2006 | Venture Round | £600k | 3 |
g-Nostics ^{} | 11/2006 | Venture Round | £552k | 1 |
Concurrent Thinking ^{} | 10/2006 | Venture Round | $3.19M | 3 |
Streamline Computing ^{} | 10/2006 | Venture Round | £1.8M | 3 |
Helveta ^{} | 10/2006 | Venture Round | £2M | 2 |
Application Developments plc ^{} | 7/2006 | Venture Round | $596k | 1 |
Rostima ^{} | 5/2006 | Venture Round | £150k | 1 |
Sphere Medical Holding ^{} | 4/2006 | Venture Round | £6.2M | 4 |
Inetec ^{} | 3/2006 | Venture Round | £3M | 3 |
Txt4 ^{} | 3/2006 | Venture Round | $2.18M | 3 |
Ad.IQ ^{} | 3/2006 | Venture Round | £1.5M | 3 |
Oxford BioTherapeutics ^{} | 3/2006 | Venture Round | £600k | 2 |
Helveta ^{} | 1/2006 | Venture Round | £300k | 1 |
Veryan Medical ^{} | 12/2005 | Venture Round | £1.25M | 4 |
Rostima ^{} | 12/2005 | Venture Round | £75k | 1 |
g-Nostics ^{} | 11/2005 | Venture Round | £422k | 2 |
SCL ^{} | 11/2005 | Venture Round | £3M | 2 |
Celoxica ^{} | 10/2005 | Venture Round | £6.4M | 5 |
InfoBasis ^{} | 10/2005 | Venture Round | £550k | 1 |
Rostima ^{} | 8/2005 | Venture Round | £75k | 1 |
Oxonica ^{} | 7/2005 | Venture Round | £8M | 4 |
Oxitec ^{} | 6/2005 | Venture Round | £1.3M | 2 |
Scancell ^{} | 5/2005 | Venture Round | £1.25M | 3 |
Oxford BioTherapeutics ^{} | 3/2005 | Venture Round | £525k | 2 |
g-Nostics ^{} | 1/2005 | Venture Round | £250k | 1 |
Helveta ^{} | 1/2005 | Series A | $1.11M | 1 |
Rostima ^{} | 12/2004 | Venture Round | £650k | 1 |
InfoBasis ^{} | 8/2004 | Venture Round | £450k | 1 |
g-Nostics ^{} | 6/2004 | Venture Round | £750k | 1 |
Protek-dor ^{} | 6/2004 | Venture Round | £247k | 1 |
Scancell ^{} | 4/2004 | Venture Round | £1.3M | 4 |
Hardide Coatings ^{} | 4/2004 | Venture Round | £1.2M | 2 |